Abstract: Software deployment to network devices in cloud computing environments subject to data control policies is provided in a manner that ensures compliance with the data control policies. A deployment service is located in a remote cloud computing environment separate from the cloud computing environments to which software is being deployed. The deployment service does not have access to restricted data in the cloud computing environments, including access control data, such that the deployment service cannot directly interact with network devices. The deployment service issues deployment requests to hardware proxies in the cloud computing environments. In response to the requests, the hardware proxies obtain access control data to access the network devices and issue commands to install the software on the network devices.

Abstract: Releases to the production environment of a cloud computing environment are deployed in a manner that maintains control over restricted data and the data plane of the cloud computing environment. A DevOps personnel is tasked with developing the release. However, the DevOps personnel is not authorized to deploy the release to the cloud computing environment because the DevOps personnel does not have access to restricted data in the cloud computing environment or the ability to modify the cloud computing environment to gain access to restricted data. Operating personnel who has access to restricted data and the right to modify the cloud computing environment is notified of the release and given release specifications providing details of the release. If the operator approves the release, the release is transferred to the cloud computing environment. A deployment engine then automatically deploys the release to the production environment of the cloud computing environment.

Abstract: The present invention generally relates to concentrated natamycin suspension formulations for inhibition of fungal growth. Specifically, the present invention relates to stable suspension concentrate formulations comprising from about 25% to about 48% w/w natamycin, from about 0.1% to about 10% w/w of an anionic surfactant selected from the group consisting of polyelectrolyte polymers, modified styrene acrylic polymers, dioctyl sodium sulfosuccinates, sodium salts of naphthalene sulfonates, and combinations thereof, and water. The formulations of the present invention contain natamycin as particles which are on average less than 11 microns in diameter and the formulations have a viscosity of less than 1400 centipoise at 21 degrees Celsius.

Abstract: A JIT service in a cloud computing environment manages just-in-time access to resources in the cloud computing environment for DevOps personnel who do not have persistent access to restricted data or the ability to modify the cloud computing environment to gain access to restricted data. When JIT access to a resource is requested by a DevOps device, the JIT service retrieves a JIT policy for the resource that includes geolocation criteria limiting the geolocation from which JIT access can be automatically granted. The geolocation of the DevOps device is evaluated against the geolocation criteria. If the geolocation criteria and any other criteria of the JIT policy are satisfied, the JIT service provisions JIT access to the resource for the DevOps device.

Abstract: A JIT service in a cloud computing environment manages just-in-time access to resources in the cloud computing environment for DevOps personnel who do not have persistent access to restricted data or the ability to modify the cloud computing environment to gain access to restricted data. When JIT access to a resource is requested by a DevOps device, the JIT service retrieves a JIT policy for the resource that includes screening criteria limiting automatic granting of JIT access to DevOps personnel who meeting the screening criteria. Screening information for the DevOps personnel is evaluated against one or more screening requirements set forth by the screening criteria. If the screening criteria and any other criteria of the JIT policy are satisfied, the JIT service provisions JIT access to the resource for the DevOps device.

Abstract: Releases to the production environment of a cloud computing environment are deployed in a manner that maintains control over restricted data and the data plane of the cloud computing environment. A DevOps personnel is tasked with developing the release. However, the DevOps personnel is not authorized to deploy the release to the cloud computing environment because the DevOps personnel does not have access to restricted data in the cloud computing environment or the ability to modify the cloud computing environment to gain access to restricted data. Operating personnel who has access to restricted data and the right to modify the cloud computing environment is notified of the release and given release specifications providing details of the release. If the operator approves the release, the release is transferred to the cloud computing environment. A deployment engine then automatically deploys the release to the production environment of the cloud computing environment.

Abstract: The present invention generally relates to concentrated natamycin suspension formulations for inhibition of fungal growth. Specifically, the present invention relates to stable suspension concentrate formulations comprising from about 25% to about 48% w/w natamycin, from about 0.1% to about 10% w/w of an anionic surfactant selected from the group consisting of polyelectrolyte polymers, modified styrene acrylic polymers, dioctyl sodium sulfosuccinates, sodium salts of naphthalene sulfonates, and combinations thereof, and water. The formulations of the present invention contain natamycin as particles which are on average less than 11 microns in diameter and the formulations have a viscosity of less than 1400 centipoise at 21 degrees Celsius.

Abstract: The present invention relates to a novel method for high throughput detection of wide range of genotoxins in eukaryotic cells wherein the eukaryotic cell based tool combines the ability to detect a broad spectrum of genotoxic signaling events and a simple and reproducible assay technique. The present invention further comprises expression cassettes, vectors, and eukaryotic cell lines for the same.

Abstract: The present invention relates to a recombinant DNA expression/secretion system in E. coli wherein the said system combines the potential of signal peptide-based translocation of recombinant proteins to the periplasmic space of E. coli with membrane brave defective mutants of E. coli to further aid secretion into the extracellular space. The present invention further relates to the expression system which furthermore includes a helper plasmid to drive the expression of translocons to facilitate improved periplasmic secretion of the over-expressed recombinant protein. In addition, this system also facilitates efficient production of specific proteins of interest in E. coli.

Abstract: The present invention relates to a novel method for high throughput detection of wide range of genotoxins in eukaryotic cells wherein the eukaryotic cell based tool combines the ability to detect a broad spectrum of genotoxic signaling events and a simple and reproducible assay technique. The present invention further comprises expression cassettes, vectors, and eukaryotic cell lines for the same.

Abstract: Compositions, kits, and methods for detecting cellulolytic microorganisms in a sample are disclosed herein. In some embodiments cellulolytic microorganisms are detected by detecting the presence of a secreted enzyme, such as but not limited to cellobiohydrolase.

Abstract: A novel bacterial strain of Bacillus thuringiensis, VBTS 2528, is described. This strain comprises genes encoding Cry1Ac, Cry 1Ca, and Cry2Aa endotoxin proteins. The invention further relates to an insecticidal composition comprising a mixture of VBTS 2528 and to methods for controlling insect pests utilizing VBTS 2528.

Abstract: The invention relates to low VOC plant growth regulator compositions comprising less than about 25% of volatile organic compounds (VOCs). The compositions comprise forchlorfenuron (CPPU). Also provided are methods of using the compositions.

Abstract: The invention relates to low VOC plant growth regulator compositions comprising less than about 25% of volatile organic compounds (VOCs). The compositions comprise forchlorfenuron (CPPU). Also provided are methods of using the compositions.

Abstract: A novel bacterial strain of Bacillus thuringiensis, VBTS 2528, is described. This strain comprises genes encoding Cry1Ac, Cry 1Ca, and Cry2Aa endotoxin proteins. The invention further relates to an insecticidal composition comprising a mixture of VBTS 2528 and to methods for controlling insect pests utilizing VBTS 2528.

Abstract: The invention relates to low VOC plant growth regulator compositions comprising less than about 25% of volatile organic compounds (VOCs). The compositions preferably comprise 6-benzyladenine (6-BA) or forchlorfenuron (CPPU). Also provided are methods of using the compositions.